Abbey Olsen

Abbey Olsen

Auto-generated profile, based on publicly available information

Abbey Olsen

Department of Veterinary and Animal Sciences, University of Copenhagen, Grønnegårdsvej 8, Frederiksberg C 1870, Denmark

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2015 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
AOAbbey Olsen
Abbey Olsen
KFKlaas Frankena Frankena
Klaas Frankena Frankena
RBRene’ Bødker
Rene’ Bødker
NTNils Toft
Nils Toft
STStig Milan Thamsborg
Stig Milan Thamsborg
THTariq Halasa
Tariq Halasa
Fasciola hepatica, a trematode parasite (liver fluke), infects a wide range of host species causing fasciolosis. The disease is prevalent world-wide and causes considerable economic losses to the livestock industry. Fasciolosis is regarded as an emerging food-borne zoonosis. To promote awareness among farmers and to implement strategies to control the infection, this study examined the prevalence, spatial distribution and risk factors for F. hepatica infection in Danish cattle herds. A retrospective population based study was performed using meat inspection data of approximately 1.5 million cattle slaughtered in the period 2011 to 2013. Annual cumulative prevalence of recorded liver fluke findings was calculated for each year. Global and local spatial cluster analysis was used to identify and map spatial patterns of F. hepatica positive and negative herds to explore environmental indicators of infection. Herd level, trade and environmental risk factors were evaluated for association with infection using logistic regression. Herd infection status as predicted from the final risk factor model was compared with the observed status using heat maps to assess how well the model fitted the observed spatial pattern. During the investigated period (2011–2013), an increase in annual herd prevalence was noted (2011–25.6%; 2012–28.4%; 2013–29.3%). The spatial analysis suggested significant clustering of positive and negative herds. Presence of streams, wetlands and pastures on farms showed a significant association with the presence of infection in cattle herds. Buying animals from positive herds was a risk factor on conventional farms. Additionally, risk of being infected with F. hepatica was higher in non-dairy herds of medium size (≥30 and < 100) when compared to dairy and large (≥100) cattle herds. The observed spatial pattern could be reproduced by predictions of the risk factor model. This study showed an increase in annual herd level prevalence (2011 to 2013) indicating that an increasing proportion of herds are infected with F. hepatica infection every year in Denmark. Fasciolosis was found to be associated with both herd and environmental factors where the infection was influenced by local factors that clustered geographically.

1 May 2019 in Parasite Epidemiology and Control
Verified
Journal Article
Open access
AOAbbey Olsen
Abbey Olsen
RBRebecca Berg
Rebecca Berg
MTMaarja Tagel
Maarja Tagel
KMKärt Must
Kärt Must
GDGunita Deksne
Gunita Deksne
PJPikka Jokelainen
Pikka Jokelainen
Toxoplasma gondii is an important foodborne zoonotic parasite. Meat of infected animals is presumed to constitute a major source of human infection and may be a driver of geographical variation in the prevalence of anti-T. gondii antibodies in humans, which is substantial in the Nordic-Baltic region in northern Europe. However, data on seroprevalence of T. gondii in different animal species used for human consumption are scattered. We conducted a systematic review of seroprevalence studies and meta-analysis to estimate the seroprevalence of T. gondii in five animal species that are raised or hunted for human consumption in the Nordic-Baltic region: domestic pigs (Sus scrofa domesticus), sheep (Ovis aries), cattle (Bos taurus), wild boars (Sus scrofa), and moose (Alces alces). We searched for studies that were conducted between January 1990 and June 2018, and reported in articles, theses, conference abstracts and proceedings, and manuscripts. Subgroup analyses were performed to identify variables influencing the seroprevalence. From a total of 271 studies identified in the systematic review, 32 were included in the meta-analysis. These comprised of 13 studies on domestic pigs, six on sheep, three on cattle, six on wild boars, and four on moose. The estimated pooled seroprevalence of T. gondii was 6% in domestic pigs (CI95%: 3-10%), 23% in sheep (CI95%: 12-36%), 7% in cattle (CI95%: 1-21%), 33% in wild boars (CI95%: 26-41%), and 16% in moose (CI95%: 10-23%). High heterogeneity was observed in the seroprevalence data within each species. In all host species except wild boars, the pooled seroprevalence estimates were significantly higher in animals >1 year of age than in younger animals. Not all studies provided information on animal age, sensitivity and specificity of the serological method employed, and the cut-off values used for defining an animal seropositive. A substantial proportion of animals raised or hunted for human consumption in the region had tested positive for T. gondii. This indicates widespread exposure to T. gondii among animals raised or hunted for human consumption in the region. Large variations were observed in the seroprevalence estimates between the studies in the region; however, studies were too few to identify spatial patterns at country-level.

23 August 2023 in Food Control
Verified
Journal Article
Open access
AOAbbey Olsen
Abbey Olsen
SBSilvia Bonardi
Silvia Bonardi
LBLisa Barco
Lisa Barco
MSMarianne Sandberg
Marianne Sandberg
NLNina Langkabel
Nina Langkabel
EKEija Kaukonen
Eija Kaukonen

1 December 2020 in Preventive Veterinary Medicine
Verified
Journal Article
Open access
AOAbbey Olsen
Abbey Olsen
MSMarianne Sandberg
Marianne Sandberg
HHHans Houe
Hans Houe
HNHenrik Vedel Nielsen
Henrik Vedel Nielsen
MDMatt Denwood
Matt Denwood
LALis Alban
Lis Alban
Pigs are one of several host species for Toxoplasma gondii parasites, and consumption of infected pork may lead to toxoplasmosis in humans. We estimated seroprevalence in sows and finishers from conventional and organic herds in Denmark and discussed the strategies for reducing the risk from pork. We collected 447 blood samples from 59 herds, and additional meat-juice samples from 212 of the same pigs. Using a T. gondii IgG commercial ELISA test, we found 2% (95% CI = 0.4%-5%) apparent seroprevalence of T. gondii in conventional finishers, 11% (95% CI = 6%-17%) in organic finishers, 19% (95% CI = 11%-30%) in conventional sows and 60% (95% CI = 47%-72%) in organic sows. The odds of an animal testing positive for T. gondii was 16 times higher (95% CI = 4.6-74.3) in organic compared to conventional herds. The odds were 22 times higher (95% CI = 6.5-88.3) if the animal was a sow compared to a finisher. Meat-juice ELISA values were significantly correlated with plasma results (P < 0.001), but on average 64% of the blood-plasma ELISA values. Lowering the recommended cut-off from 20 to 13 percent positive values of the positive control for meat-juice ELISA, resulted in the meat-juice ELISA identifying 93% of the plasma positives as positive and 99% of the plasma negatives as negative. The time taken to detect one or more infected pigs from a T. gondii positive herd at slaughter was estimated using abattoir data on pigs (17,195,996) and batches (165,569) delivered to Danish abattoirs in 2018. The time to detection was affected by the seroprevalence, frequency at which the pigs were delivered, the number of samples tested per batch delivery and the batch sizes. Time to detection was long in conventional finisher herds due to low prevalence, and in sow herds because of intermittent delivery of a low number of sows. In organic finisher herds, time to detection was short due to medium prevalence and frequent delivery of a high number of finishers. Conventional finisher herds may be classified as low-risk, organic finisher herds as medium-risk, and conventional and organic sow herds as high-risk herds. Risk-mitigation strategies at processing plants (freezing or curing) or at the consumer level (heat treatment) for meat originating from high-risk herds, surveillance of medium-risk herds, and auditing for controlled housing (high biosecurity) in low-risk herds may be cost-effective alternatives to serological surveillance of all Danish pig herds.

14 June 2024 in Food Control
Verified
Journal Article
Open access
JCJoão B Cota
João B Cota
NLNina Langkabel
Nina Langkabel
LBLisa Barco
Lisa Barco
AOAbbey Olsen
Abbey Olsen
SBSilvia Bonardi
Silvia Bonardi
EKEija Kaukonen
Eija Kaukonen

12 August 2025 in Preventive Veterinary Medicine
Verified
Journal Article
Open access
HJHelene Ane Jensen
Helene Ane Jensen
AOAbbey Olsen
Abbey Olsen
MAMaja Louise Arendt
Maja Louise Arendt
PSPeter Sandøe
Peter Sandøe
SNSøren Nielsen
Søren Nielsen
We conducted a systematic literature review of randomised controlled trials (RCTs) on the use of cannabidiol (CBD) as a supplementary treatment for refractory idiopathic epilepsy in dogs. The objective was to summarise the efficacy and adverse effects of CBD treatment and assess the potential risk of bias in conducted studies, including an assessment of the effects thereof on the evaluation of CBD for clinical use. Studies were included in the review if they were RCTs comparing groups of dogs with refractory idiopathic epilepsy treated with CBD oil or placebo oil, respectively. The outcomes had to be efficacy and adverse effects of the treatment. English-language reports of studies published in any year were considered. A total of three studies were included in the review. All studies suggested a reduction in seizure frequency during CBD treatment, and all observed ataxia as an adverse effect of CBD treatment or a reason for withdrawal from the studies. Additionally, studies found increased levels of serum alkaline phosphatase (ALP) in dogs treated with CBD. Adverse effects included vomiting and diarrhoea, changes in appetite, behavioural changes and somnolence. The studies were characterised by a moderate to high risk of bias, which affected their validity and reliability. Based on the existing literature, it is not possible to draw conclusions concerning the efficacy and potential adverse effects of CBD as a supplementary treatment for refractory idiopathic epilepsy in dogs, and more high-quality studies are needed to evaluate clinical efficacy, the optimal treatment dose and adverse effects.